Mirae Asset Global ETFs Holdings
EWTX icon

Mirae Asset Global ETFs Holdings’s Edgewise Therapeutics EWTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$996K Buy
31,614
+245
+0.8% +$7.07K ﹤0.01% 1527
2025
Q4 		$778K Buy
31,369
+19
+0.1% +$381 ﹤0.01% 1663
2025
Q3 		$508K Sell
31,350
-8,628
-22% -$122K ﹤0.01% 1864
2025
Q2 		$524K Sell
39,978
-3,798
-9% -$54.8K ﹤0.01% 1798
2025
Q1 		$963K Buy
43,776
+2,463
+6% +$64.6K ﹤0.01% 1520
2024
Q4 		$1.1M Buy
41,313
+1,595
+4% +$50.8K ﹤0.01% 1495
2024
Q3 		$1.06M Buy
39,718
+10,432
+36% +$208K ﹤0.01% 1513
2024
Q2 		$527K Buy
+29,286
New +$511K ﹤0.01% 1801

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's EWTX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Edgewise Therapeutics (EWTX) stake by 0.78% in Q1 2026, buying an estimated $7.07K and bringing the position to 31,614 shares worth $996K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Mirae Asset Global ETFs Holdings first reported a position in EWTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.1M in Q4 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 31,614 shares of Edgewise Therapeutics worth $996K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 245 Edgewise Therapeutics shares in Q1 2026, an estimated $7.07K.
  • Edgewise Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1527 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Edgewise Therapeutics position peaked at $1.1M in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.